Pfizer Inc. (NYSE: PFE) announced today the completion of a global, ex-China, licensing agreement with 3SBio, Inc. (01530.HK) ...

The country's gross domestic product (GDP) growth is targeted at between 4.5 per cent and 5.5 per cent per annum during the ...

Gov. Maura Healey wants to infuse the state's research and jobs sector with hundreds of millions of dollars as Massachusetts ...

(NASDAQ:MRNA) today reported financial results and provided business updates for the second quarter of 2025. "In the last three months, we advanced our pipeline with positive Phase 3 flu vaccine ...

As China's economy has successfully maintained its resilience and high-quality development in the first half of 2025 thanks ...

Integra LifeSciences Holdings Corporation (Nasdaq: IART), a leading global medical technology company, today reported ...

Tech India's AI-first strategy reshapes developer roles, with AI automating routine tasks while developers focus on complex ...

Along with its second-quarter results on July 29, Merck MRK announced a new multi-year optimization initiative, which is ...

Ligand to invest $35 million in exchange for a tiered royalty on future sales of Orchestra's AVIM therapy and Virtue SAB and an additional $5 million in an equity private placement • Medtronic to inve ...

We’re pretty proud to be ‘Made in Wisconsin, ’” Ashwinraj Karthikeyan said. “All of our products, even those we would sell ...

Sarepta Therapeutics' recent setbacks and restructuring have pressured Arrowhead's share price. Read why I am reiterating my bullish rating on ARWR stock.

Uganda Clays Limited (UCL), has posted a net loss of UGX 4.95 billion for 2024, deepening from UGX 2.85 billion in 2023.